Pentixapharm Ag
Clinical trials sponsored by Pentixapharm Ag, explained in plain language.
-
Trial halted: new scan tested for better cancer detection
Diagnosis TerminatedThis study aimed to test whether a new PET scan imaging agent called [68Ga]Ga-PTF could better detect and stage marginal zone lymphoma compared to the standard FDG PET scan. The trial involved 13 adult patients with newly diagnosed lymphoma who had not yet received treatment. Par…
Phase: PHASE3 • Sponsor: Pentixapharm AG • Aim: Diagnosis
Last updated Apr 02, 2026 14:58 UTC
-
Can a brain scan predict Cancer's return?
Knowledge-focused TerminatedThis study aimed to see if a special type of PET scan, using a tracer called [68Ga]Ga-PentixaFor, could predict how well patients with primary or isolated secondary brain lymphoma would respond to chemotherapy. The goal was to check if a scan taken partway through treatment could…
Phase: PHASE2 • Sponsor: Pentixapharm AG • Aim: Knowledge-focused
Last updated Mar 23, 2026 15:15 UTC